Biotech Startups
10,099 companies tagged Biotech, with their investors and founders.
Verndari develops the VaxiPatch, a single-dose vaccination kit that uses intradermal microarray technology for vaccine delivery. The company focuses on vaccine delivery methods designed to be pain-free and thermostable, with pre-clinical studies indicating higher efficacy than traditional delivery.
0 investors
0 investors
0 investors
Verseon uses quantum physics-based modeling combined with AI to design novel small-molecule drug candidates for major human diseases. Its pipeline targets conditions including cardiovascular disease (anticoagulants), diabetic vision loss, multidrug-resistant cancers, and solid-tumor metastasis, with candidates ranging from preclinical to clinical stages.
0 investors
Verthermia develops HEATT (Hyperthermic Extracorporeal Applied Tumor Therapy), a whole-body hyperthermia treatment that heats a patient's blood in an external circuit to raise body temperature and target cancer cells, combined with dialysis to rebalance body chemistry. The therapy is used to treat cancers and other diseases and is administered in a hospital operating room setting.
0 investors
Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.
0 investors
0 investors
Vesicor develops precision-engineered cellular microvesicles that deliver p53 mRNA to cancer cells using a non-viral, immune-silent platform, aiming to restore tumor suppression in advanced solid tumors. Its lead candidate, ecm-RV/p53, and broader platform are designed for oncology therapeutics and multiple payload types.
0 investors
0 investors
0 investors
VETmAb BIO is a veterinary biotechnology company developing monoclonal antibody (mAb) therapeutics for dogs and cats. It targets veterinarians treating companion animals, and its founding team previously built and sold KindredBio.
0 investors
0 investors
0 investors
Vicora develops a thrombectomy catheter with an integrated vibrating distal tip for removing blood clots such as those from deep vein thrombosis and pulmonary embolism. The medical device company is in pre-clinical testing and targets clinicians treating venous thromboembolism.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Villya Pharmaceuticals develops water-soluble reformulations of existing drugs using a patented carbohydrate-loading technology, including liquid praziquantel, a topical gel for Female Genital Schistosomiasis, second-generation erectile dysfunction medications, and oral peptide therapeutics such as semaglutide and insulin. The company focuses on improving solubility, gastric stability, and delivery of pharmaceuticals to enable oral administration of otherwise injectable medicines.
0 investors
0 investors
0 investors
ViQi develops AI and imaging solutions to accelerate bioassay development for the bioprocessing industry. The company combines expertise in computer vision, machine learning, and bioprocessing to address challenges in life sciences research and manufacturing.
0 investors